Phathom Pharmaceuticals (PHAT) Equity Ratio (2022 - 2025)
Historic Equity Ratio for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to 1.76.
- Phathom Pharmaceuticals' Equity Ratio fell 26373.62% to 1.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.76, marking a year-over-year decrease of 26373.62%. This contributed to the annual value of 0.67 for FY2024, which is 28124.65% down from last year.
- According to the latest figures from Q3 2025, Phathom Pharmaceuticals' Equity Ratio is 1.76, which was down 26373.62% from 1.62 recorded in Q2 2025.
- Phathom Pharmaceuticals' Equity Ratio's 5-year high stood at 0.26 during Q1 2022, with a 5-year trough of 1.76 in Q3 2025.
- For the 4-year period, Phathom Pharmaceuticals' Equity Ratio averaged around 0.53, with its median value being 0.45 (2022).
- In the last 5 years, Phathom Pharmaceuticals' Equity Ratio surged by 30253.81% in 2023 and then plummeted by 120253.71% in 2024.
- Phathom Pharmaceuticals' Equity Ratio (Quarter) stood at 0.45 in 2022, then soared by 61.27% to 0.18 in 2023, then tumbled by 281.25% to 0.67 in 2024, then tumbled by 162.34% to 1.76 in 2025.
- Its Equity Ratio stands at 1.76 for Q3 2025, versus 1.62 for Q2 2025 and 1.15 for Q1 2025.